Home » Newsletters » BioWorld

BioWorld

June 11, 1993

View Archived Issues

INTERNATIONAL AIDS CONFERENCE T CELLS AND AIDS PROGRESSION

DYNAGEN TESTS NICERASE

COLLABORATION TO DEVELOP MABS TO TREAT CANCER

MYCOGEN BIOPESTICIDE REGISTERED IN CANADA

INTERNATIONAL AIDS CONFERENCE PDL REPORTS RESULTS

TELOR UNDERWRITERS EXERCISE OPTION

INTERNATIONAL AIDS CONFERENCE QUICKER HIV TEST

LABELING FOODS CARRIES A HIGH PRICE TAG

LEGACY GETS RIGHTS TO TECHNOLOGY

IMCLONE UNDERWRITERS PURCHASE SHARES

RAC APPROVES CELLPRO PROTOCOLS

BRITISH BIO BEGINS TRIAL OF ENZYME INHIBITORS

EPA APPROVES NEEM-BASED BIOINSECTICIDES

INTERNATIONAL AIDS CONFERENCE EARLY AZT USE DEFENDED

INTERNATIONAL AIDS CONFERENCE CELL THERAPY SHRINKS TUMORS IN EARLY TRIAL

AFFYMETRIX GETS $500,000 SBIR

WARNER-LAMBERT TO INVEST IN NEUREX

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...